LOS ANGELES--(BUSINESS WIRE)--City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, announced today that its CEO, Robert Stone, has been named to Modern Healthcare’s prestigious list of the 100 Most Influential People in Health Care.
This distinction, one of the highest honors in health care, acknowledges transformative leaders who are shaping the future of the industry. Stone was specifically honored for his visionary leadership in expanding access to leading-edge cancer research and lifesaving treatments across the nation.
Under his guidance, City of Hope has become one of the nation’s largest integrated cancer networks, noted for rapidly delivering leading biomedical research and world-renowned care. The organization has also emerged as a national model for closing the access gap to advanced cancer care, ensuring that groundbreaking discoveries are swiftly translated into treatments delivered directly to patients.
“This recognition is a testament to the extraordinary contributions of the people with whom I have the honor of working at City of Hope,” said Stone, chief executive officer and the Helen and Morgan Chu Chief Executive Officer Distinguished Chair at City of Hope. “Our team is made up of trailblazers in cancer research and treatments driven by compassion and a relentless commitment to delivering cures to more people and families facing cancer. Together, we are making hope a reality for cancer patients everywhere.”
Now operating in five major metropolitan regions, City of Hope provides access to advanced cellular therapies, precision medicine, a robust clinical trials network and nationally acclaimed supportive care services.
Stone’s leadership has propelled City of Hope to become a global leader in cancer research, with many of the world’s most renowned experts in immunology, genetics and other key disciplines. City of Hope is at the forefront of innovations in gene therapy, recombinant DNA technology, computational medicine and biology. City of Hope’s groundbreaking research impacts millions of people worldwide each year, making a profound difference in the fight against cancer.
The complete ranking is available in Modern Healthcare magazine, with profiles of the winners at ModernHealthcare.com/100MostInfluential.
About City of Hope
City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the U.S., and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked top 5 in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHope™. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.
